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Abstract
Background
Transfusion-transmissible viral infections, such as hepatitis C virus (HCV), hepatitis B virus
(HBV), and human immunodeficiency virus (HIV), remain a major public health problem in
developing countries. The prevalence of these viral infections among blood donors may
reflect the burden of these diseases among populations. Therefore, the aim of this study
was to assess the sero-prevalence of transfusion-transmissible viral infections among blood
donors.
Methods
A retrospective study was conducted using data obtained from registration books of blood
donors from the Ethiopian North Gondar District Blood Bank from 2010 to 2012. Descriptive
statistics, such as percentages, medians and interquartile ranges were computed. A binary
logistic regression model was fitted to identify factors associated with each viral infection.
The odds ratio with a 99% confidence interval was calculated. A p-value < 0.01 was consid-
ered statistically significant.
Result
A total of 6,471 blood donors were included in the study. Of these, 5,311 (82.1%) were
male, and 382 (5.9%) were voluntary blood donors. Overall, 424 (6.55%) of the blood
donors were sero-reactive for at least one transfusion-transmissible viral infection. Of all
study participants, 233 (3.6%) were sero-reactive for HBV, 145 (2.24%) were sero-reactive
for HIV, and 51 (0.8%) were sero-reactive for HCV. Four (0.062%) of the study’s participants
were co-infected: 3 (75%) with HBV-HCV and 1 (25%) with HIV-HBV-HCV. Being a farmer,
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unemployed or employed donor was significantly associated with transfusion-transmissible
viral infections compared to being a student donor.
Conclusion
The prevalence of transfusion-transmissible viral infections is substantial and has
increased overtime. Hence, it demands more vigilance in routine screening of donated
blood prior to transfusion. Further community-based studies to identify societal risk fac-
tors are necessary.
Introduction
Blood transfusion saves millions of lives worldwide each year [1]. However, transfusion-trans-
missible infections (TTIs) are a major problem associated with blood transfusion, particularly
in developing countries [1]. The magnitude of this problem is directly related to the prevalence
of TTIs among blood donors [2]. In several settings, human immunodeficiency virus (HIV),
hepatitis B virus (HBV), and hepatitis C virus (HCV) are the major TTIs [3–5]. Each blood
transfusion carries a risk of transmitting blood-borne pathogens [6]. For instance, in sub-Saha-
ran Africa, 5–12% of patients who received blood transfusions are at risk of post-transfusion
hepatitis and HIV infections [7]. For this reason, the prevention and control of TTIs is the
leading concern and priority of the World Health Organization (WHO) and blood transfusion
programs in Sub-Saharan African countries, including Ethiopia [8].
TTIs can pose risks for healthcare workers. Because the prevalence of transfusion-transmis-
sible pathogens is high in the general population, the occupational risk of exposure to these
pathogens for healthcare workers poses a major public health challenge. According to WHO
estimates, 3 million healthcare workers experience percutaneous exposures to blood pathogens
worldwide each year. Of these, 2 million are exposed to HBV [9]. A study conducted in Bulle
Hora, Ethiopia, showed that HBV was higher among healthcare workers (7.3%) than non-
healthcare workers (0.9%) [10].
The prevalence of TTIs among blood donors varies across the world, as well as within coun-
tries, contingent on the prevalence of these viruses in the general population [11,12]. Accord-
ing to a WHO report, Ethiopia is classified under geographical regions with intermediate to
hyper-endemic viral hepatitis infections [13]. The prevalence of viral hepatitis varies within
districts and target groups in Ethiopia [14–23]. The overall pooled prevalence of HBV was
7.4%. In sub-groups, the prevalence varied at 5.2% in HIV infected individuals, 8.0% in com-
munity based studies, 8.4% in blood donors, 11.0% in immigrants, and 6.9% in other groups
[24]. Similarly, the prevalence of HCV and HIV is common in Ethiopia with regional differ-
ences. A study conducted among clinically suspected cases in Gondar indicated a high preva-
lence of HCV at 12.4% [14].
Several programs have been implanted in Ethiopia to reduce the burden of HBV in the
community. These programs include the following: the Expanded Programme on Immuniza-
tion Policy, updated in 2007 and including childhood immunization against HBV using a pen-
tavalent form at ages 6, 10 and 14 weeks after birth; implementing antenatal screening for
HBsAg of all pregnant women and the vaccination of their babies at birth; and recommending
the vaccination of high risk groups such as health professionals against HBV. However, these
programs have not been routinely enforced in most healthcare settings across the country[25].
A study conducted among healthcare workers in Bahir Dar, northwest Ethiopia, reported that
Transfusion-transmissible viral infections among blood donors
PLOS ONE | https://doi.org/10.1371/journal.pone.0180416 July 5, 2017 2 / 12
HBsAg, Hepatitis B Surface Antigen; HCV, Hepatitis
C Virus; HIV, Human Immunodeficiency Virus; TTI,
Transfusion transmitted infection; WHO, World
Health Organization.
HBV vaccination status was low. Only 5.4% reported that they took three or more doses of the
HBV vaccine [26]. Similarly, another study revealed that the status of the HBV vaccination
among surgeons practicing in Ethiopia was low, with only 24 out of 98 surgeons (23.5%) hav-
ing received the vaccination [27].
Quality-guaranteed screening of all donated blood for TTIs, including HIV, HBV, and
HCV, is recommended by the WHO and adopted by the Ethiopian government for the provi-
sion of safe and efficacious blood and blood components [28]. This includes the selection of
eligible blood donors, the collection of blood, the processing and testing of the donated blood,
the issuing of compatible blood, and safe administration of the blood to recipients. In response
to this strategy, Ethiopia revoked responsibilities for blood transfusion from the Ethiopian Red
Cross Society and granted it to the National Blood Transfusion Service Agency, a government
agency managed under the Federal Ministry of Health and Regional Health bureau created in
2010 to ensure blood safety and accessibility [29]. Twenty-five blood banks were functional in
the country in 2014. The North Gondar District Blood Bank is one of the blood banks located
in northwest Ethiopia [29].
Monitoring time trends in TTIs among blood donors provides evidence to assess the effec-
tiveness of blood supply screening programs, and may indicate changes in disease prevalence
in communities. There are few epidemiological studies conducted in Ethiopia on TTIs among
blood donors [16–18,20,21]. However, data are limited between 2010 and 2012 in northwest
Ethiopia for the analysis of trends. Therefore, the aim of this study was to assess the sero-preva-
lence of HBV, HCV, and HIV among blood donors at the North Gondar District Blood Bank,
northwest Ethiopia, between 2010 and 2012.
Materials and methods
Study design and setting
A retrospective cohort study was conducted at the North Gondar District Blood Bank among
blood donors who donated blood from 2010 to 2012. The Blood Bank is in Gondar town,
located 738 km northwest of the capital city, Addis Ababa. It provides services for a catchment
population of approximately five million people in North Gondar and neighboring districts.
On average, the blood bank collects 2,500 units annually. The majority of this blood is used for
emergency, surgical, and gynecological cases.
Study population
Study participants were all blood donors who donated blood at the North Gondar District
Blood Bank from 2010 to 2012. They consisted of voluntary and replacement (family) blood
donors who weighed more than 50 kg and were older than 17 years of age. A total of 6,471
blood donor records were reviewed and included in the study.
Serological investigations
Serum or plasma samples were tested for HBV, HIV and HCV using the Enzyme Linked
Immunosorbent Assay (ELISA) (HIV1/2: Vironostika HIV Uni-Form II Ag/Ab fourth genera-
tion ELISA, Bio-Merieux, Boxtel, Netherlands; HBsAg: a third generation ELISA, Hepanostika
HBsAg UNi-Form II, Bio-Merieux, Boxtel, Netherlands; HCV: Human anti-HCV third gener-
ation ELISA, HumanGasellschaft for Bio-chemical and diagnostic MbH, Germany). All tests
were performed according to the manufacturer’s instructions.
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Data collection and statistical analysis
Data on socio-demographic variables and laboratory test results were collected from blood
donors’ registration books using the data extraction format. Collected data were then cross-
checked for completeness, entered into Epi Info software (version 3.5.1), and then transferred
to SPSS version 20 software for analysis. Descriptive statistics were performed, and the results
were presented in tables. Both bivariate and multivariable binary logistic regression models
were fitted to identify factors associated with each viral infection. The odds ratio and its 99%
confidence interval were used to determine the strength of the association. A p-value<0.01 in
the multivariable binary logistic regression analysis was considered to be statistically significant.
Ethical considerations
The study was conducted after ethical clearance was obtained from the School of Biomedical
and Laboratory Sciences, College of Medicine and Health Sciences, the University of Gondar.
Permission was also obtained from the head of North Gondar District Blood Bank. Data were
kept in a confidential manner. As the study used secondary data, informed consent was not
sought from study participants.
Results
Demographic characteristics
A total of 6,471 individuals donated blood and were screened for viral infections during the
three year period at the Gondar District Blood Bank. Approximately 5,311 (82.1%) and 3,070
(47.4%) of the blood donors were males and aged 18–25 years, respectively. The median age of
the participants was 26 years (range: 48 years). Almost all of the 6,089 (94.1%) blood donations
were obtained from a replacement donation (Table 1).
Transfusion-transmissible viral infection prevalence
Overall, 424 (6.55%; 99% CI: 5.76%, 7.34%) blood donors had serological evidence for at least
one TTI (i.e., HBV, HCV, or HIV). Four (0.062%) blood donors were co-infected with more
Table 1. Demographic characteristics of blood donors at the North Gondar District Blood Bank, northwest Ethiopia, 2010 to 2012.
Variables Categories Frequency Percent
Age (years) 18–25 3,070 47.4
26–35 2,191 33.9
36–45 846 13.1
>45 364 5.6
Sex Male 5,311 82.1
Female 1,160 17.9
Occupation Student 1,842 28.5
Farmer 1,728 26.7
Government employed 947 14.6
Private employed 296 4.6
Self-employed 1,068 16.5
Unemployed 590 9.1
Type of donation
Voluntary 382 5.9
Replacement 6,089 94.1
https://doi.org/10.1371/journal.pone.0180416.t001
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than one viral infection: 3(75%) with HBV-HCV and 1(25%) with HIV-HBV-HCV infections.
The number of donors gradually increased from 2,006 (31.0%) in 2010 to 2,294 (35.4%) in
2012. The overall prevalence of TTIs also increased from 100 (5.0%) in 2010 to 213 (9.28%) in
2012 (Table 2).
Sero-prevalence and associated factors of HBV infection
The overall sero-prevalence of HBV was 233 (3.6%; 99%CI: 3.0%, 4.2%) and was 4.14% among
males and 3.48% among females. In the multivariable binary logistic regression analysis,
farmer (AOR = 2.20; 99%CI: 1.25, 3.89), employed (AOR = 2.48; 99%CI: 1.46, 4.23), and
unemployed (AOR = 4.00; 99%CI: 2.15, 7.46) donors were at a higher risk of HBV infection
compared to student donors. In addition, the odds of HBV among people who donated blood
in 2012 were almost two times as likely of having HBV among people who donated blood in
2010 (AOR = 1.84; 99%CI: 1.20, 2.80) (Table 3).
Table 2. Frequency of HIV, HBV and HCV infections with respect to donation year among blood donors at the North Gondar district Blood Bank,
northwest Ethiopia.
Year of
donation
Total screened
N (%)
HBV positive
N (%)
HCV positive
N (%)
HIV positive
N (%)
Total sero- prevalence (HBV, HCV, or HIV) N (%)
2010 2,006 (31.0%) 57 (2.8%) 12 (0.6%) 36 (1.8%) 100 (5.0%)
2011 2,171(33.5%) 55 (2.5%) 10 (0.5%) 46 (2.1%) 111 (5.11%)
2012 2,294 (35.4%) 121 (5.3%) 29 (1.3%) 63 (2.7%) 213 (9.28%)
Total 6,471(100%) 233 (3.6%) 51 (0.8%) 145 (2.24%) 424 (6.55%)
https://doi.org/10.1371/journal.pone.0180416.t002
Table 3. Sero-prevalence of HBV infection according to socio-demographic characteristics of blood donors at the North Gondar District Blood
Bank, northwest Ethiopia.
Variables HBV COR (99%CI) AOR (99%CI)
Reactive Non-reactive
Age group
18–25 103 2,967 1.00
26–35 75 2,116 1.02(0.69, 1.52)
36–45 37 809 1.32(0.8, 2.2)
>45 18 346 1.49(0.76, 2.2)
Sex
Male 185 5,126 1.00
Female 48 1,112 1.2(0.78, 1.8)
Occupation
Student 32 1,810 1.00 1.00
Farmer 63 1,665 2.14(1.24, 3.77) 2.20(1.25, 3.89)
Employed* 97 2,214 2.49(1.45, 4.21) 2.48(1.46, 4.23)
Unemployed 41 549 4.22(2.3, 7.9) 4.00(2.15, 7.46)
Type of donation
Voluntary 5 377 1.00
Replacement 228 5,861 2.93(0.91, 9.74)
Year of donation
2010 57 1,949 1.00 1.00
2011 55 2,116 0.89 (0.54, 1.45) 0.87 (0.53, 1.43)
2012 121 2,173 1.90 (1.23, 2.90) 1.84 (1.20, 2.80)
COR: Crude Odds Ratio; AOR: Adjusted Odds Ratio; CI: Confidence Interval; and
*Employed: government employed, private employed and self-employed
https://doi.org/10.1371/journal.pone.0180416.t003
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Sero-prevalence and associated factors of HCV infection
The sero-prevalence of HCV infection among blood donors was 51 (0.80%; 99%CI: 0.5%,
1.1%). In the bivariate binary logistic regression analysis, being a blood donor older than 45
years in 2012 and employed was significantly associated with HCV infection. However, in the
multivariable analysis, being employed and a blood donor in 2012 were the only significant
factors associated with HCV infection. The odds of HCV among those who donated blood in
2012 were two times higher than among those who donated blood in 2010 (AOR = 2.09; 99%
CI: 1.85, 5.09). Similarly, the odds of HCV among people who were employed donors were
almost four times higher than among student donors (AOR = 4.35; 99%CI: 1.23, 15.23)
(Table 4).
Sero-prevalence and associated factors of HIV infection
The HIV prevalence among blood donors was 145 (2.24%; 99%CI: 1.8%, 2.7%). HIV sero-prev-
alence was 2.3% in males and 0.71% in females. The age-specific distribution of HIV infection
revealed that a high prevalence was detected among blood donors who were older than 45 years
at 14 (3.9%). In the bivariate binary logistic regression analysis, age, occupation, and year of
blood donation were significantly associated with HIV infection. However, in the multivariable
analysis, only occupation was significantly associated HIV infections. Farmers (AOR = 4.02;
95%CI: 1.79, 9.03), employed (AOR = 3.75; 99%CI: 1.70, 8.28), and unemployed (AOR = 5.97;
99%CI: 2.43, 14.61) donors were more likely to be infected with HIV than student donors
(Table 5).
Table 4. Sero-prevalence of HCV infection according to socio-demographic characteristics of blood donors at the North Gondar District Blood
Bank, northwest Ethiopia.
Variables HCV COR (99%CI) AOR (99%CI)
Reactive Non-reactive
Age group
18–25 16 3,054 1.00
26–35 22 2,169 1.94(0.83, 4.53)
36–45 6 840 1.4(0.40, 4.70)
>45 7 357 3.74(1.15, 12.13)
Sex
Male 44 5,267 1.00
Female 7 1,153 0.73(0.25, 2.08)
Occupation
Student 5 1,837 1.00 1.00
Farmer 14 1,714 3.00 (0.78, 11.51) 3.12 (0.81, 12.00)
Employed* 27 2,284 4.34 (1.23, 15.26) 4.35 (1.23, 15.23)
Unemployed 5 585 3.13 (0.61, 16.08) 2.91 (0.56, 14.95)
Year of donation
2010 12 1,994 1.00 1.00
2011 10 2,161 0.76 (.025, 2.32) 0.74 (0.86, 5.08)
2012 29 2,265 2.13 (0.87, 5.17) 2.09 (1.85, 5.09)
COR: Crude Odds Ratio; AOR: Adjusted Odds Ratio; CI: Confidence Interval; and
*Employed: government employed, private employed and self-employed
Type of donation was not included in the model because it has zero values in one of the cell.
https://doi.org/10.1371/journal.pone.0180416.t004
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Discussion
Blood transfusion is considered to be a potential risk factor for the transmission of viruses
such as HBV, HCV and HIV, which are life-threatening and global public health problems. In
this study, we found that the overall sero-prevalence of TTIs was 6.55% (99% CI: 5.76–7.34%),
which is in agreement with a previous report from Hawassa, Ethiopia (7.0%) [16]. However,
this prevalence is lower than other studies conducted in different part of Ethiopia, such as
Gondar (9.5%) [15], Bahir Dar (43.2%) [18], Wolaita Sodo (29.5%) [17], and Jijiga (11.5%)
[21]. The prevalence reported in this study was also lower compared to other African countries
that reported an overall prevalence of viral infection ranging from 9.5% to 21.2% [30–32]. This
may be because our study focused only on three viral infections (i.e., HIV, HBV, and HCV),
whereas previous studies included these viral infections in addition to syphilis. Another possi-
ble reason for this low prevalence of TTIs in our study could be due to differences in time
period because our study used data collected in 2010 to 2012. This is relatively recent when
compared to data used by the majority of the above studies [15,18,30,31].
Our study revealed that the sero-prevalence of TTIs increased from 5.0% in 2010 to 9.28%
in 2012. Although it does not demonstrate the trend of TTIs in the study area, as it is a three
year retrospective data set, it may suggest that either the overall prevalence of TTIs is increased
in the community overtime or the sensitivity of the test methods used to screen donated blood
are improved as a result of changes in policies and strategies that governments have enforced
to control TTIs. Another reason for this might be related to the shift of duty from the Red
Cross Society to the National Blood Transfusion Service Agency in 2010 [29]. After 2010, the
Table 5. Sero-prevalence of HIV infection according to socio-demographic characteristics of blood donors at the North Gondar District Blood
Bank, northwest Ethiopia.
Variables HIV COR (99%CI) AOR (99%CI)
Positive Negative
Age group
18–25 46 3,024 1.00
26–35 58 2,133 1.79(1.07–3.00)
36–45 27 819 2.17(1.2–4.10)
>45 14 350 2.63(1.18–5.85)
Sex
Male 123 5,188 1.00
Female 22 1,138 0.82(0.45–1.50)
Occupation
Student 13 1,829 1.00 1.00
Farmer 48 1,680 4.02 (1.79, 9.03) 4.02 (1.79, 9.03)
Employed* 60 2,251 3.75 (1.67, 8.28) 3.75 (1.70, 8.28)
Unemployed 24 566 5.96 (2.44, 14.61) 5.97 (2.43, 14.61)
Type of donation
Voluntary 4 378 1.00
Replacement 141 5,948 2.24(0.6–8.33)
Year of donation
2010 36 1,970 1.00
2011 46 2,125 1.18 (0.66, 2.11)
2012 63 2,231 1.55 (1.89, 2.66)
COR: Crude Odds Ratio; AOR: Adjusted Odds Ratio; CI: Confidence Interval; and
*Employed: government employed, private employed and self-employed
https://doi.org/10.1371/journal.pone.0180416.t005
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National Blood Transfusion Service Agency developed national blood policy, standards, oper-
ating procedures, and guidelines to ensure the safety and accessibility of blood. This involved
advocating the importance of blood donation, recruiting blood donors via campaigns, and rig-
orous testing of donated blood for TTIs. This creates the opportunity to recruit more blood
donors who have risky behavior for TTIs, which ultimately increases the magnitude of the
problem. In support of this argument, our study revealed that the odds of HBV and HCV
infections among people who donated blood in 2012 were almost two times higher compared
to people who donated blood in 2010.
In our study, the sero-prevalence of HBV among blood donors was 3.6% (99%CI: 3.0%,
4.2%), which is lower compared to previous studies conducted in Ethiopia [15,16,18–21,33]
and elsewhere in the world [30,34–37]. This lower prevalence might be attributed to differ-
ences in the specificity and sensitivity of the screening test. The blood bank in the Gondar dis-
trict uses a conventional HBSAg test (i.e., the third generation ELISA test) for the screening of
HBV. The conventional donor screening for HBsAg may yield serologically negative results
despite the presence of HBV DNA [38]. Studies have shown that 20% of occult HBV infections
are negative for all HBV seromarkers [39]. Therefore, if molecular techniques had been used
for the screening, the magnitude most likely would have been more than the current finding.
The other explanation might be a difference in the geographical variations that have been
reported in the occurrence of viral infections, as well as a difference in the mode of prospective
donor selection and study populations. However, when compared with the global prevalence
of chronic HBV infection category, it is within the range of intermediate clusters (2–7%) [40],
indicating that HBV is common in the study area.
The prevalence of HCV infection in this study was 0.8% (99%CI: 0.5%, 1.1%). Comparable
figures were reported in Gondar, Ethiopia (0.7%) [15], Hawassa, Ethiopia (0.6%) [16], and
Dessie, Ethiopia (0.61%) [33]. However, a higher prevalence was observed in previous studies
carried out in Ethiopia [18–20] and elsewhere in the world [30,37,41–44]. On the other hand,
a lower prevalence was observed in previous studies done in Jijiga, Ethiopia (0.4%) [21]. The
possible explanation for the variation in the magnitude of HCV infections across studies might
be due to differences in risk behaviors across different geographical locations and differences
in socio-cultural practices. Cultural practices such as tattooing and sharing of contaminated
materials, such as needles are common among uneducated people [45]. These practices could
increase the risk of being infected with HCV. Employed donors were four times more likely to
be infected with HCV when compared to student donors. This might be related to occupa-
tional injuries, such as needle sticks in healthcare settings [46,47].
Regarding the prevalence of HIV infection, our study demonstrated that 2.24% (99%CI:
1.8%, 2.7%) of blood donors were sero-reactive, which is similar to the result obtained from
the Ethiopian Demographic and Health Survey Report [48]. The highest prevalence of HIV
infection (4.1%) was observed in donors who were unemployed. Similar results have been
reported in previous studies [15,49,50]. This might be due to low socio-economic levels of
unemployed donors, as they are most likely to indulge in risky sexual relationships that may
expose them to TTIs. Employed donors were also at higher risk of HIV-infection compared to
student donors. The reason for high prevalence of TTIs among employed donors as compared
to student donors might be related to increased exposure to TTIs, most likely due to the possi-
bility of engaging in more risky behaviors over time and the transfusion of unsafe blood and/
or blood products in their lifetime. Similarly, farmers were also at higher risk of having HIV
infection than students. This might be related with the lower awareness of farmers about the
mode of transmission and prevention of HIV. Previous studies conducted in Ethiopia showed
that farmers had poor knowledge about HIV prevention methods, which may lead to unpro-
tected sexual practices [51].
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The overall prevalence of HIV, HBV and HCV co-infection in our study was 4 (0.062%).
Different studies conducted in Ethiopia also report that the co-infection rate of these TTIs
range from 0.19 to 4.8% [15,16,32]. The most common co-infection was HBV-HCV (75%).
Comparable results were observed in Hawassa, Ethiopia (66.7%) [16], and Ghana (45.5%)
[37]. The occurrence of co-infections could be because these infections share similar modes of
transmission [34].
The highest prevalences of HBV (7.0%) and HIV (4.1%) were observed in those donors
who were unemployed. This is supported by findings from other studies [15,49,50]. Similarly,
unemployed donors were four times more likely to be infected with HBV and six times more
likely to be infected with HIV than student donors. This might be due to low socio-economic
levels of unemployed donors, as they are most likely to indulge in risky sexual relationships
that may expose them to TTIs. Moreover, as a consequence of economic problems, unem-
ployed donors may experience risky practices, such as sharing of personal care items like
razors or toothbrushes, sharing of sharp kitchen materials, and having sexual contact with a
person infected with TTIs. Furthermore, farmer donors were two times more likely to be
infected with HBV and four times more likely to be infected by HIV compared to student
donors. This might be due to risky cultural practices such as tattooing and sharing of sharp
materials, which are common in uneducated people, including farmers [45]. Such practices
could increase the risk of infection with transfusion-transmissible pathogens.
The limitation of this study is related to the retrospective nature of its design in that it did
not include all risk factors associated with TTIs. With this limitation, the study attempted to
demonstrate the sero-prevalence of the major TTIs among blood donors in the North Gondar
District.
Conclusion
The prevalence of TTIs is substantial and has increased over time. Being a farmer, unemployed
and employed were found to be significantly associated with TTIs. Hence, more vigilance in
routine screening of donated blood prior to transfusion is needed. Further community-based
studies to identify societal risk factors for blood-borne pathogens are necessary.
Supporting information
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